ARCHIVES

DCPC Advisors Commit $32 Mil. To Chemoprevention

This article is from The Cancer Letter archive.

Vol. 17 No. 23 | June 7, 1991

Download PDF Visit The Full Archive

Related Articles

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

June 5, 1992

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

March 2, 2001

NCAB Meeting Moved To October

July 20, 1979

In Brief: Children’s Hospital Of Boston Names Pizzo Physician-In-chief; Lynch Wins Bristol Award

March 22, 1996

ACS Says 41 Percent Survive 5 Years

January 2, 1981

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998